Key autophagy genes such as ULK1, ATG3, ATG4D, or ATG5 are significantly downregulated in primary AML patient samples, and their expressions can be restored upon ATRA therapy in APL patients and AML cell lines. This evidence concerns the gene ATG5 and acute promyelocytic leukemia.